BioNTech SE BNTX
NASDAQ BNTX
$97.27 -1.03 (-1.05%)
As of: Oct 1, 2026 · 1:14 PM EDT

BioNTech SE (BNTX) Non Operating Income (2022 - 2024)

Updated

BioNTech SE's Non Operating Income came in at $17.71 million for Q1 2024, up 101.2% from $8.8 million a year earlier.

Analysis

BioNTech SE (BNTX) Non Operating Income (2022 - 2024) Analysis & Trends

Over the trailing twelve months to Mar 31, 2024, BioNTech SE reported Non Operating Income of $105.29 million.

  • The Q1 2024 figure represents the highest quarterly Non Operating Income since Q3 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -73.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 387.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 BioNTech SE 24.86 Bn -34.51 Bn 10.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 17.71 Mn
Sep 30, 2023 16.87 Mn
Mar 31, 2023 8.80 Mn
Sep 30, 2022 61.91 Mn
API Access

BioNTech SE Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=BNTX&period=max&api_key=YOUR_API_KEY